Login / Register The Most Trusted Name in Medical Education


Elsevier's Office of CME offers a variety of courses for the nursing community.

Newborn image 1

Mosby's Essential Nursing CE: Newborn Series

Format: eLearning Activity

Mosby's Essential Nursing CE Newborn Series, sponsored by an educational grant from Mead Johnson Nutrition, is authored and peer reviewed by nurse experts. The four web-based, interactive, multimedia lessons are designed for perinatal nurses, and include a printable Lesson Notebook that is a detailed lesson outline for personal note taking. Elsevier provides the continuing education contact hours.* 

  1. Care of the Stable Newborn -  0.62 contact hours
  2. Newborn and Infant Nutrition -   0.71 contact hours
  3. Newborn Physiology -  0.54 contact hours
  4. Physical Assessment of the Newborn -  0.81 contact hours
*Elsevier is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Elsevier is provider approved by the Florida Board of Nursing. The provider number is #50-4681. Elsevier is provider approved by the California Board of Registered Nursing. The provider number is CEP 3257.

Click here to register and start earning free contact hours.


MadID 116x140

Combating Drug Resistant Gram-negative Infections: Giving Conventional Antibodies New Capabilities

Format: Webcast

Gram-negative (GN) bacterial infections present a daunting challenge for clinicians, as they can be especially hard to treat and are associated with high morbidity and mortality, particularly when dealing with carbapenem-resistant Enterobacteriaceae (CRE) and other antibiotic-resistant pathogens. While the development of novel antibiotic classes to overcome resistance has been lacking, recent advances in the development of next-generation agents as of well-established classes has the potential to help address the critical need for effective therapies for serious, drug-resistant GN infections. As such, it is crucial for members of the infectious disease clinical team who treat these patients to understand how these emerging therapies differ from their more conventional predecessors, how they may effectively fit into current treatment paradigms, and how to effectively approach dosing and therapeutic drug management in order to optimize health outcomes for these difficult-to-treat patients.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™, 1.0 nursing contact hours, 1.0 ACPE Credits

Management of Patients with Relapsed/Refractory Multiple Myeloma: Elsevier CME Independent Conference Highlights from EBMT and EHA 2018

Format: Conference Reporter

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

In this CME-accredited webcast, three experts discuss the clinical implications of some of the latest important research on relapsed/refractory multiple myeloma (RRMM). The roundtable discussion covers new data presented at the 2018 annual meetings of the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT). The topics discussed include: unmet needs in the treatment of RRMM; new data on treatment strategies (including the roles of proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies); and emerging treatments, such as chimeric antigen receptor (CAR) T-cell therapies.

Credits: 1.0 AMA PRA Category 1 Credit™
Thumbnail webcast 116X140

The Role of Micronutrients, Vitamins, and Supplements in Transforming Patient Health

Format: Webcast

This activity combines data presented at the recent 21st International Congress of Nutrition with clinical practice guidelines, published evidence, and expert faculty insights to provide practical approaches for learners to the assessment of micronutrient deficiencies in patients, how micronutrient intake requirements change in different populations, and the use of supplementation as an effective means to address shortfalls and improve patient health.

Take Course »

Credits: 2.5 AMA PRA Category 1 Credit™, 2.5 nursing contact hours
Banner 3 Webcast dog ear 116x140

An Update on Emerging Therapies for Cystic Fibrosis and Their Implications for Clinical Outcomes: Independent CME Conference Highlights from the 2018 European Cystic Fibrosis Society (ECFS) Conference

Format: Webcast

With the rapid progress in the field of cystic fibrosis (CF), healthcare providers are continuously challenged to keep abreast of the latest data in the treatment and management of CF to achieve optimal care of people with CF. This activity provides analyses and clinical perspectives of new and emerging clinical trials data on CFTR modulators presented at the 2018 European Cystic Fibrosis Society (ECFS) Conference*. International expert faculty will examine these latest data, deliberate on the challenges associated with the evaluation of new agents, and discuss the implications of these data for people with CF.

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

Take Course »

Credits: 1.5 AMA PRA Category 1 Credit™
910737 116x140 edit2

Best Practices in Intrathecal Therapy for Chronic Pain: Patient Selection, Treatment Initiation, and Ongoing Monitoring

Format: Webcast Series

Welcome to this Chronic Pain CME Snapshot™ video series. Each 15-minute module offers focused, clinically actionable education for pain specialists, nurses and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. For a comprehensive curriculum that provides a practical set of recommendations on improving daily functioning and quality of life among patients with chronic pain, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit™.

Take Course »

Credits: 0.25 AMA PRA Category 1 Credit™ per module; 0.25 AANP Contact Hours (coming soon)
910701 116 x 144

Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

Format: Webcast Series

This CME-accredited CME Snapshot™ educational series, Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care is intended for primary care clinicians and other health care providers involved in the ongoing management of patients with chronic obstructive pulmonary disease (COPD). Within each focused activity, an expert pulmonologist and a primary care educator discuss best practices for a specific aspect of managing patients with COPD, including monitoring the disease course over time, maximizing patient function, and individualizing treatment regimens. One activity also addresses patients’ perspectives by incorporating patient-clinician interactions and insights into disease burdens, challenges to good long-term outcomes, and shared decision-making. 

Take Course »


Credits: Up to 1.00 AMA PRA Category 1 Credit(s)™
910726 116 x 140

Aerosolized Agents for Airway Clearance in Cystic Fibrosis: When, How, Why? A Roundtable Discussion

Format: Webcast

This activity is presented as a roundtable discussion between three international expert faculty in cystic fibrosis (CF). This expert faculty will discuss the role of aerosolized agents for improving airway clearance, including caveats from their own extensive clinical experience in managing patients with this condition. The faculty will also deliberate on strategies to improve patient adherence to CF therapy in a case study based format. These discussions will support participants in clinical decision making as well as in helping their patients achieve optimal benefit through adherence to their CF therapy.


Take Course »


Credits: 1.50 AMA PRA Category 1 Credit(s)™
910742E 116 x 140


Format: Webcast

The content for this activity is based on the live, inter professional seminar titled, “The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis” that was presented at the 31st Annual North American Cystic Fibrosis Conference in Indianapolis, Indiana. This CME/CNE activity will highlight the latest advances in CFTR-based therapeutics for the treatment of patients with cystic fibrosis. The expert faculty will utilize an interactive panel format to present and discuss recent trial data as it relates to clinical decision-making, including updates regarding the assessment, monitoring, and management of patients treated with CFTR modulated therapies. This educational activity is intended to increase the knowledge and competencies of the multidisciplinary team involved in the care of the CF patient population. Upon completion of this educational activity, the healthcare team will be better equipped with vital information for improving outcomes and quality of life in patients with cystic fibrosis.

Take Course »


Credits: 1.50 AMA PRA Category 1 Credit(s)™ 1.50 Nursing Contact Hours
ASM 116x140

Addressing the Urgent Threat: Strategies for Combating Hard-To-Treat Bacterial Infections

Format: Webcast

In the United States, as many as 2 million patients are annually diagnosed with antibiotic-resistant Gram-positive or Gram-negative (GP/GN) infections. Unfortunately, the development of novel antibiotics has lagged dangerously behind the emergence of resistant infections, leaving these patients with limited treatment options. Recently, several novel antibiotics have been approved, and more are in the clinical pipeline, many of which have proven to be particularly effective in patients with harder-to-treat GP and/or GN pathogens. However, in the absence of the judicious use of these new antibiotics, acquired resistance to these new agents is inevitable. This archived symposium will provide participants with the opportunity to review the clinical utility of new and investigational antimicrobials while also focusing on strategies to promote careful, appropriate antibiotic utilization. Interactive patient case scenarios will allow clinicians to apply acquired knowledge of antibiotic use to real-world examples of treating patients with GP/GN infections.

Take Course »

Credits: 2.0 AMA PRA Category 1 Credits™
MEDX ONC 116x140

Patient-Centered Care for Genitourinary Cancers

Format: Webcast

Community oncologists are challenged to stay up to date with updated clinical practice guidelines on the personalization of treatments for genitourinary (GU) cancers, including prostate, urothelial, and renal cancers, combination/sequential therapies, emerging safety and efficacy data from ongoing studies of novel regimens, and strategies to facilitate patient engagement in order to improve patient outcomes. Clinicians need tools and resources to help educate their patients and empower them to participate in their care and make educated treatment choices. Advanced-stage GU cancers consists of a spectrum of disease that requires an integrated multidisciplinary approach supported by a uro-oncologic team. Therefore, it is critical to educate these clinicians on their roles within the multidisciplinary cancer care team and on the importance of effective communication with other members of the team to maximize patient outcomes.

Take Course »

Credits: 1.25 AMA PRA Category 1 Credits™ ; 1.2 Nursing contact hours; 1.25 ACPE hours
910745 116x141

Evolving Treatment Paradigms for Rheumatoid Arthritis: Translating Comprehensive Patient Evaluations Into Personalized Therapy

Format: Webcast Series

Welcome to this RA CME Snapshot™ video series. Each 15-minute module offers focused, clinically actionable education for rheumatologists and other clinicians who manage patients with RA. For a comprehensive curriculum on current evidence-based guidelines and newly published data on the use of targeted inhibitors of interleukin (IL)-6 or Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways, clinicians can complete all 6 video modules for a total of 1.5 AMA PRA Category 1 Credits™ or 1.5 hours of nursing contact hours.

Take Course »

Credits: 1.5 AMA PRA Category 1 Credits™

Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability

Format: Webcast

Effective treatment of major depressive disorder with antidepressants is currently limited by factors that affect treatment compliance, including delay in onset of therapeutic effects and, often, intolerable side-effects. Recent data suggest that use of antidepressant combinations with different mechanisms of action may be a better first-line strategy prior to augmentation with other drug classes. The rationale for this approach is that combining multiple pharmacological actions affecting multiple monoamine targets produces greater efficacy. The latest data on multimodal therapies indicate shorter onset of therapeutic effects and improved tolerability. By modulating multiple receptors and neurotransmitter systems, it is hoped that these new agents may also treat some of the associated symptoms of major depressive disorder, such as anxiety and cognitive dysfunction.


Credits: 3.0 AMA PRA Category 1 Credits™